GeneType to Enter Canadian and New Zealand Markets
July 09, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType to Enter Canadian and New Zealand Markets
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024 08:00 ET
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
April 16, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GTG to pilot GeneType in Breast Screen centers across the U.S.
April 11, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.
Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test
June 16, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
US Patent Office Grants Key Risk Test Patent
June 18, 2020 08:00 ET
|
Genetic Technologies Ltd
Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 – Methods of assessing risk...